Microfactory
In vitro microfluidic testing systems and efficacy screening for cosmetic brands, ingredient manufacturers and researchers
Highlights
- New on EvolcAdded 2026-11-14
About Microfactory
Microfactory develops microfluidic technologies and provides in vitro testing to evaluate cosmetic ingredients and formulations. Its systems assess interactions with sebum, sweat and lacrimal fluids, including makeup durability, skincare barrier effects and antiperspirant efficacy.
It works with cosmetic brands, ingredient manufacturers and researchers, offering testing services and technologies for purchase. The company is based in Paris and was founded in 2014.
Product: Proprietary U-Skin™, Smart-Pore™ and T-Skin™ microfluidic systems for in vitro cosmetic efficacy testing.
Jobs at Microfactory
Leadership
- Fabrice Monti · CEOSource: company website
More biotech & pharma companies
Microphyt
Microalgae-based ingredients for health, nutrition, well-being and beauty businessesMimabs
Preclinical antibody and ADC development services for biotech, pharmaceutical and academic research partnersMinakem
Develops and manufactures active pharmaceutical ingredients for pharmaceutical and healthcare companiesNew on EvolcMitem Pharma
Develops and commercializes essential and niche medicines for patients with serious conditionsNew on EvolcMSD France
Develops medicines and vaccines for patients and public health needs in France and worldwide
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.